vitamin D3
Commercial- Indications
- Vitamin D deficiency, Congenital ichthyosis
Company intelligence / Profile preview
Zhejiang Garden Biopharmaceutical is the largest Chinese producer of vitamin D3 with an integrated industrial chain for lanolin cholesterol, cholecalciferol, 25-hydroxyvitamin D3, and refined lanolin. It supplies both feed-grade and pharmaceutical-grade products globally. The company commercialized 25-hydroxyvitamin D3 as one of only four companies worldwide with this capability[8]. Its business performance is closely tied to global vitamin prices[10].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Garden Biopharmaceutical.